Product-Related Factors and Immunogenicity of Biotherapeutics

被引:0
|
作者
Murli Krishna
机构
[1] Bristol-Myers Squibb Company,
来源
关键词
Biotherapeutic; Immunogenicity risk; CQA; Aggregation; Posttranslational modifications; Impurities; Glycosylation; Product risk assessment;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:219 / 231
页数:12
相关论文
共 50 条